Key result
TAVR linked to fewer complications and lower mortality vs open surgery in solid-organ transplant recipients.
Why the study?
Solid-organ transplant recipients have a unique surgical risk profile with elevated perioperative complications, making optimal aortic stenosis treatment uncertain.
May support TAVR preference in transplant recipients with severe AS; leaves open need for randomized confirmation.
Key Points Solid‐organ transplant recipients have a unique surgical risk profile. The elevated risk of perioperative complications in these patients makes TAVR a particularly attractive option when aortic stenosis treatment is needed. The authors report that TAVR is associated with fewer complications in transplant patients, including lower mortality, than open surgery. These data are welcome, as they assist our collective effort in choosing safe and effective therapeutic options in special patient groups.
No takes yet. Share an insight, caveat, or question.
Postalian et al. (2021) conducted an editorial in Severe aortic stenosis in solid-organ transplant recipients. TAVR vs. Open surgery was evaluated on Complications and mortality. TAVR is associated with fewer complications, including lower mortality, compared to open surgery in solid-organ transplant recipients with severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: